Medicinal – Page 177

Cryptococcal endophthalmitis in a patient with malignancy: A case report and literature review

mycolabadmin

A 50-year-old woman with advanced lung cancer developed a rare fungal eye infection caused by Cryptococcus neoformans, resulting in blurred vision. Doctors diagnosed this through eye surgery and fluid analysis, then treated her with strong antifungal medications both injected into the eye and given systemically. After 10 months of treatment, her vision significantly improved, showing that early detection and aggressive antifungal therapy are critical for preventing blindness from this rare infection.

Comparative Multi-Omics Analysis and Antitumor Activity of Phylloporia crataegi and Phylloporia fontanesiae

mycolabadmin

Researchers compared two types of medicinal fungi (Phylloporia crataegi and P. fontanesiae) to understand why one is more effective at fighting cancer. Using advanced molecular analysis techniques, they found that P. crataegi contains higher levels of cancer-fighting compounds and activates more genes related to cancer cell death. These findings suggest that these fungi could be promising sources for developing new cancer treatments.

In vitro activity of SF001: a next-generation polyene versus amphotericin B

mycolabadmin

This study tested a new antifungal drug called SF001 against a well-established antifungal called amphotericin B. Researchers tested both drugs against common fungal infections affecting vulnerable patients. SF001 was found to work as well as or better than amphotericin B, particularly against harder-to-treat Aspergillus fungi, while potentially causing fewer side effects.

Antifungal potential of copper oxide nanoparticles against Microsporum canis isolates in canine and feline dermatophytosis

mycolabadmin

Researchers tested tiny copper oxide particles created using plant extracts against a fungus that causes ringworm in dogs and cats. These nanoparticles successfully killed the fungus in laboratory tests, with effectiveness at concentrations ranging from 500-2,000 parts per million. While slightly less effective than current medications, the nanoparticles showed promise as an alternative treatment, especially important as the fungus becomes resistant to traditional drugs.

Mycobiome of Stool, Blood, Thrombus and Vessel Wall in Abdominal Aortic Aneurysm Patients

mycolabadmin

This study examined fungal communities in blood, stool, and damaged aorta tissues from patients with abdominal aortic aneurysm, a serious condition where the main blood vessel weakens and bulges. Researchers found that healthy blood vessels contain protective fungi called Tomentella, while damaged vessels have high levels of harmful fungi called Malassezia. Interestingly, the fungi found in damaged vessel walls may not come directly from the gut, suggesting they originate from other body parts like the mouth or skin. These findings suggest that controlling fungal communities with targeted antifungal treatments might help prevent or slow aneurysm development.

Green Valorization Strategies of Pleurotus ostreatus and Its By-Products: A Critical Review of Emerging Technologies and Sustainable Applications

mycolabadmin

Oyster mushrooms generate large amounts of agricultural waste including stems, leftover plant material, and spent growing substrate. These waste products contain many healthy compounds like fiber, β-glucans, and antioxidants that are usually thrown away. Scientists are developing new extraction technologies using ultrasound, microwaves, and other methods to recover these beneficial compounds from mushroom waste for use in functional foods like meat products, baked goods, and dairy items, reducing waste while creating healthier food ingredients.

Acetophenone-Based 3,4-Dihydropyrimidine-2(1H)-Thione as Potential Inhibitor of Tyrosinase and Ribonucleotide Reductase: Facile Synthesis, Crystal Structure, In-Vitro and In-Silico Investigations

mycolabadmin

Scientists created a new chemical compound that shows promise in fighting skin cancer, particularly melanoma. The compound is seven times more effective at blocking tyrosinase, an enzyme involved in skin pigmentation and cancer growth, compared to existing drugs. Computer simulations and laboratory tests confirmed that this compound can also interfere with DNA replication processes that cancer cells depend on, suggesting it could be developed into a new cancer treatment with fewer side effects.

Invasive Cutaneous Mucormycosis in a Patient With Chronic Lymphocytic Leukemia on Obinutuzumab, Idelalisib, and Bruton Tyrosine Kinase Degrader: A Case Report

mycolabadmin

A 74-year-old man with leukemia developed a serious fungal infection (mucormycosis) on his ankle while taking cancer-fighting drugs. The infection was diagnosed through tissue biopsy examination rather than standard culture tests. Treatment required both powerful antifungal medications and surgical removal of the infected leg below the knee. The patient recovered successfully after this aggressive treatment approach.

Epidemiological profile of dermatophytes at the parasitology-mycology laboratory at Mohammed VI University Hospital in Oujda

mycolabadmin

This study examined fungal skin infections caused by dermatophytes in a Moroccan hospital over four years, analyzing 950 samples. The researchers found that nail infections (onychomycosis) were most common, particularly in people over 50 years old, while scalp infections mainly affected children. The fungus Trichophyton rubrum was responsible for most infections, though Microsporum canis increasingly caused scalp infections, likely due to increased pet ownership in Morocco. The study emphasizes the importance of proper laboratory testing to identify the specific fungus and choose appropriate treatment.

Identification of (Z)-2-benzylidene-dihydroimidazothiazolone derivatives as tyrosinase inhibitors: Anti-melanogenic effects and in silico studies

mycolabadmin

Scientists developed new chemical compounds that can block tyrosinase, an enzyme that produces skin pigment (melanin). These new compounds, called DHIT derivatives, work much better than existing skin lightening agents like kojic acid and appear to be safer. The best compound tested was 100 times more effective at stopping melanin production than kojic acid in laboratory tests and showed no toxicity to cells.

Research Topic: Medicinal